Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Reflex control of immunity

Key Points

  • During sterile injury or infection, the innate immune system produces cytokines as part of the innate immune response.

  • Molecules such as the cytokines tumour necrosis factor and interleukin-1 as well as high-mobility group box 1 protein are inherently toxic and can directly mediate the development of fever, shock, tissue injury, organ failure and even death.

  • Visceral reflexes provide physiological homeostasis to complex organ systems (for example, the baroreflex in the cardiovascular system), and these principles also operate in the control of innate immune responses.

  • The inflammatory reflex, a prototypical neural mechanism that modulates the immune system, consists of an afferent sensory arm that is activated by the products of sterile or infectious inflammation, and a motor arm, termed the cholinergic anti-inflammatory pathway, that inhibits pro-inflammatory cytokine release by the innate immune system.

  • The molecular mechanism of cytokine regulation by the inflammatory reflex depends on signal transduction by the nicotinic acetylcholine receptor α7 subunit (α7nAChR).

  • Administration of selective α7nAChR agonists or electrical stimulation of the inflammatory reflex inhibits pro-inflammatory cytokine release and confers protection against tissue damage.

  • The immune system is not autonomous because immune responses are influenced by the inflammatory reflex.

  • The inflammatory reflex maintains immune homeostasis as a set point function that influences the progression of inflammatory diseases.

Abstract

Inflammation can cause damage and even death. What controls this primitive and potentially lethal innate immune response to injury and infection? Molecular and neurophysiological studies during the past decade have revealed a pivotal answer: immunity is coordinated by neural circuits that operate reflexively. The afferent arc of the reflex consists of nerves that sense injury and infection. This activates efferent neural circuits, including the cholinergic anti-inflammatory pathway, that modulate immune responses and the progression of inflammatory diseases. It might be possible to develop therapeutics that target neural networks for the treatment of inflammatory disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Neural circuitry of the inflammatory reflex.
Figure 2: Mechanism of function of the efferent arc.
Figure 3: Functional anatomy of the inflammatory reflex.
Figure 4: The set point of the immune system.

Similar content being viewed by others

References

  1. Tracey, K. J. The inflammatory reflex. Nature 420, 853–859 (2002).

    Article  CAS  PubMed  Google Scholar 

  2. Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).

    Article  CAS  PubMed  Google Scholar 

  3. Tracey, K. J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest 117, 289–296 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Steinman, L. Elaborate interactions between the immune and nervous systems. Nature Immunol. 5, 575–581 (2004).

    Article  CAS  Google Scholar 

  5. Sternberg, E. M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Rev. Immunol. 6, 318–328 (2006).

    Article  CAS  Google Scholar 

  6. Bellinger, D. L. et al. Sympathetic modulation of immunity: relevance to disease. Cell Immunol. 252, 27–56 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. del Rey, A. & Besedovsky, H. O. Sympathetic nervous system–immune interactions in autoimmune lymphoproliferative diseases. Neuroimmunomodulation 15, 29–36 (2008).

    Article  CAS  PubMed  Google Scholar 

  8. Blalock, J. E. & Smith, E. M. Conceptual development of the immune system as a sixth sense. Brain Behav. Immun. 21, 23–33 (2007).

    Article  CAS  PubMed  Google Scholar 

  9. Albuquerque, E. X., Pereira, E. F., Alkondon, M. & Rogers, S. W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89, 73–120 (2009).

    Article  CAS  PubMed  Google Scholar 

  10. van Koppen, C. J. & Kaiser, B. Regulation of muscarinic acetylcholine receptor signaling. Pharmacol. Ther. 98, 197–220 (2003).

    Article  CAS  PubMed  Google Scholar 

  11. Wess, J., Eglen, R. M. & Gautam, D. Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nature Rev. Drug Discov. 6, 721–733 (2007).

    Article  CAS  Google Scholar 

  12. Koizumi, K., Terui, N., Kollai, M. & Brooks, C. M. Functional significance of coactivation of vagal and sympathetic cardiac nerves. Proc. Natl Acad. Sci. USA 79, 2116–2120 (1982).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Dinarello, C. A. et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med. 163, 1433–1450 (1986).

    Article  CAS  PubMed  Google Scholar 

  14. Tracey, K. J. et al. Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia. J. Clin. Invest 86, 2014–2024 (1990).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Watkins, L. R. & Maier, S. F. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J. Intern. Med. 257, 139–155 (2005).

    Article  CAS  PubMed  Google Scholar 

  16. Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W. & Kelley, K. W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Rev. Neurosci. 9, 46–56 (2008).

    Article  CAS  Google Scholar 

  17. Davis, C. N. et al. MyD88-dependent and -independent signaling by IL-1 in neurons probed by bifunctional Toll/IL-1 receptor domain/BB-loop mimetics. Proc. Natl Acad. Sci. USA 103, 2953–2958 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Mattson, M. P. NF-κB in the survival and plasticity of neurons. Neurochem. Res. 30, 883–893 (2005).

    Article  CAS  PubMed  Google Scholar 

  19. Ferri, C. C., Yuill, E. A. & Ferguson, A. V. Interleukin-1β depolarizes magnocellular neurons in the paraventricular nucleus of the hypothalamus through prostaglandin-mediated activation of a non selective cationic conductance. Regul. Pept. 129, 63–71 (2005).

    Article  CAS  PubMed  Google Scholar 

  20. Watkins, L. R. et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune–brain communication. Neurosci. Lett. 183, 27–31 (1995).

    Article  CAS  PubMed  Google Scholar 

  21. Hansen, M. K., O'Connor, K. A., Goehler, L. E., Watkins, L. R. & Maier, S. F. The contribution of the vagus nerve in interleukin-1β-induced fever is dependent on dose. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R929–R934 (2001).

    Article  CAS  PubMed  Google Scholar 

  22. Goehler, L. E. et al. Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res. Bull. 43, 357–364 (1997).

    Article  CAS  Google Scholar 

  23. Wang, H. Y. & Fitzgerald, R. S. Muscarinic modulation of hypoxia-induced release of catecholamines from the cat carotid body. Brain Res. 927, 122–137 (2002).

    Article  CAS  PubMed  Google Scholar 

  24. Neubauer, J. A. & Sunderram, J. Oxygen-sensing neurons in the central nervous system. J. Appl. Physiol. 96, 367–374 (2004).

    Article  CAS  PubMed  Google Scholar 

  25. Goehler, L. E. et al. Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J. Neurosci. 19, 2799–2806 (1999).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Niijima, A. The afferent discharges from sensors for interleukin 1β in the hepatoportal system in the anesthetized rat. J. Auton. Nerv. Syst. 61, 287–291 (1996).

    Article  CAS  PubMed  Google Scholar 

  27. Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428–435 (2008).

    Article  CAS  PubMed  Google Scholar 

  28. Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1–5 (2007).

    Article  CAS  PubMed  Google Scholar 

  29. Nathan, C. Points of control in inflammation. Nature 420, 846–852 (2002).

    Article  CAS  PubMed  Google Scholar 

  30. Wang, H. et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421, 384–388 (2003).

    Article  CAS  PubMed  Google Scholar 

  31. Ghia, J. E., Blennerhassett, P. & Collins, S. M. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression. J. Clin. Invest 118, 2209–2218 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Ghia, J. E., Blennerhassett, P., Kumar-Ondiveeran, H., Verdu, E. F. & Collins, S. M. The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131, 1122–1130 (2006).

    Article  PubMed  Google Scholar 

  33. van Westerloo, D. J. et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822–1830 (2006).

    Article  CAS  PubMed  Google Scholar 

  34. van Westerloo, D. J. et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J. Infect. Dis. 191, 2138–2148 (2005).

    Article  CAS  PubMed  Google Scholar 

  35. Guarini, S. et al. Efferent vagal fibre stimulation blunts nuclear factor-κB activation and protects against hypovolemic hemorrhagic shock. Circulation 107, 1189–1194 (2003).

    Article  PubMed  Google Scholar 

  36. Bernik, T. R. et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J. Exp. Med. 195, 781–788 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Saeed, R. W. et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J. Exp. Med. 201, 1113–1123 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Huston, J. M. et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623–1628 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Charpantier, E. et al. α7 neuronal nicotinic acetylcholine receptors are negatively regulated by tyrosine phosphorylation and Src-family kinases. J. Neurosci. 25, 9836–9849 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kihara, T. et al. α7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A β-amyloid-induced neurotoxicity. J. Biol. Chem. 276, 13541–13546 (2001).

    Article  CAS  PubMed  Google Scholar 

  41. de Jonge, W. J. et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2–STAT3 signaling pathway. Nature Immunol. 6, 844–851 (2005).

    Article  CAS  Google Scholar 

  42. Dajas-Bailador, F. A., Soliakov, L. & Wonnacott, S. Nicotine activates the extracellular signal-regulated kinase 1/2 via the α7 nicotinic acetylcholine receptor and protein kinase A, in SH-SY5Y cells and hippocampal neurones. J. Neurochem. 80, 520–530 (2002).

    Article  CAS  PubMed  Google Scholar 

  43. Wang, H. et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nature Med. 10, 1216–1221 (2004).

    Article  CAS  PubMed  Google Scholar 

  44. Parrish, W. R. et al. Modulation of TNF release by choline requires α7 subunit nicotinic acetylcholine receptor-mediated signaling. Mol. Med. 14, 567–574 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Pavlov, V. A. et al. Selective α7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit. Care Med. 35, 1139–1144 (2007).

    Article  CAS  PubMed  Google Scholar 

  46. Rosas-Ballina, M. et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc. Natl Acad. Sci. USA 105, 11008–11013 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Hamano, R. et al. Stimulation of α7 nicotinic acetylcholine receptor inhibits CD14 and the Toll-like receptor 4 expression in human monocytes. Shock 26, 358–364 (2006).

    Article  CAS  PubMed  Google Scholar 

  48. Yoshikawa, H. et al. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7. Clin. Exp. Immunol. 146, 116–123 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Suzuki, T. et al. Microglial α7 nicotinic acetylcholine receptors drive a phospholipase C/IP3 pathway and modulate the cell activation toward a neuroprotective role. J. Neurosci. Res. 83, 1461–1470 (2006).

    Article  CAS  PubMed  Google Scholar 

  50. Shytle, R. D. et al. Cholinergic modulation of microglial activation by α7 nicotinic receptors. J. Neurochem. 89, 337–343 (2004).

    Article  CAS  PubMed  Google Scholar 

  51. Razani-Boroujerdi, S. et al. T cells express α7-nicotinic acetylcholine receptor subunits that require a functional TCR and leukocyte-specific protein tyrosine kinase for nicotine-induced Ca2+ response. J. Immunol. 179, 2889–2898 (2007).

    Article  CAS  PubMed  Google Scholar 

  52. Takahashi, H. K. et al. The immunosuppressive effects of nicotine during human mixed lymphocyte reaction. Eur. J. Pharmacol. 559, 69–74 (2007).

    Article  CAS  PubMed  Google Scholar 

  53. Berthoud, H. R. & Powley, T. L. Characterization of vagal innervation to the rat celiac, suprarenal and mesenteric ganglia. J. Auton. Nerv. Syst. 42, 153–169 (1993).

    Article  CAS  PubMed  Google Scholar 

  54. Berthoud, H. R. & Powley, T. L. Interaction between parasympathetic and sympathetic nerves in prevertebral ganglia: morphological evidence for vagal efferent innervation of ganglion cells in the rat. Microsc. Res. Tech. 35, 80–86 (1996).

    Article  CAS  PubMed  Google Scholar 

  55. Bellinger, D. L., Lorton, D., Hamill, R. W., Felten, S. Y. & Felten, D. L. Acetylcholinesterase staining and choline acetyltransferase activity in the young adult rat spleen: lack of evidence for cholinergic innervation. Brain Behav. Immun. 7, 191–204 (1993).

    Article  CAS  PubMed  Google Scholar 

  56. Bellinger, D. L., Felten, S. Y., Lorton, D. & Felten, D. L. Origin of noradrenergic innervation of the spleen in rats. Brain Behav. Immun. 3, 291–311 (1989).

    Article  CAS  PubMed  Google Scholar 

  57. Brandon, K. W. & Rand, M. J. Acetylcholine and the sympathetic innervation of the spleen. J. Physiol. 157, 18–32 (1961).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Leaders, F. E. & Dayrit, C. The cholinergic component in the sympathetic innervation to the spleen. J. Pharmacol. Exp. Ther. 147, 145–152 (1965).

    CAS  PubMed  Google Scholar 

  59. Bulloch, K., Damavandy, T. & Badamchian, M. Characterization of choline O-acetyltransferase (ChAT) in the BALB/C mouse spleen. Int. J. Neurosci. 76, 141–149 (1994).

    Article  CAS  PubMed  Google Scholar 

  60. Kawashima, K. & Fujii, T. Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci. 9, 2063–2085 (2004).

    Article  CAS  PubMed  Google Scholar 

  61. Kawashima, K. & Fujii, T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 74, 675–696 (2003).

    Article  CAS  PubMed  Google Scholar 

  62. von Kanel, R., Nelesen, R. A., Mills, P. J., Ziegler, M. G. & Dimsdale, J. E. Relationship between heart rate variability, interleukin-6, and soluble tissue factor in healthy subjects. Brain Behav. Immun. 22, 461–468 (2008).

    Article  PubMed  CAS  Google Scholar 

  63. Haensel, A., Mills, P. J., Nelesen, R. A., Ziegler, M. G. & Dimsdale, J. E. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 33, 1305–1312 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Marsland, A. L. et al. Stimulated production of proinflammatory cytokines covaries inversely with heart rate variability. Psychosom. Med. 69, 709–716 (2007).

    Article  CAS  PubMed  Google Scholar 

  65. Holguin, F. et al. Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest 127, 1102–1107 (2005).

    CAS  PubMed  Google Scholar 

  66. Lanza, G. A. et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am. J. Cardiol. 97, 1702–1706 (2006).

    Article  CAS  PubMed  Google Scholar 

  67. Jae, S. Y. et al. Effects of lifestyle modifications on C-reactive protein: contribution of weight loss and improved aerobic capacity. Metabolism 55, 825–831 (2006).

    Article  CAS  PubMed  Google Scholar 

  68. Goldhammer, E. et al. Exercise training modulates cytokines activity in coronary heart disease patients. Int. J. Cardiol. 100, 93–99 (2005).

    Article  PubMed  Google Scholar 

  69. Sloan, R. P. et al. Aerobic exercise attenuates inducible TNF production in humans. J. Appl. Physiol 103, 1007–1011 (2007).

    Article  PubMed  Google Scholar 

  70. Thayer, J. F. & Fischer, J. E. Heart rate variability, overnight urinary norepinephrine and C-reactive protein: evidence for the cholinergic anti-inflammatory pathway in healthy human adults. J. Intern. Med. 265, 439–447 (2008).

    Article  PubMed  CAS  Google Scholar 

  71. Thayer, J. F. & Lane, R. D. The role of vagal function in the risk for cardiovascular disease and mortality. Biol. Psychol. 74, 224–242 (2007).

    Article  PubMed  Google Scholar 

  72. Thayer, J. F. & Sternberg, E. Beyond heart rate variability: vagal regulation of allostatic systems. Ann. NY Acad. Sci. 1088, 361–372 (2006).

    Article  CAS  PubMed  Google Scholar 

  73. Stein, K. S., McFarlane, I. C., Goldberg, N. & Ginzler, E. M. Heart rate variability in patients with systemic lupus erythematosus. Lupus 5, 44–48 (1996).

    Article  CAS  PubMed  Google Scholar 

  74. Barnaby, D. et al. Heart rate variability in emergency department patients with sepsis. Acad. Emerg. Med. 9, 661–670 (2002).

    Article  PubMed  Google Scholar 

  75. Pontet, J. et al. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J. Crit. Care 18, 156–163 (2003).

    Article  PubMed  Google Scholar 

  76. Evrengul, H. et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol. Int. 24, 198–202 (2004).

    Article  PubMed  Google Scholar 

  77. Laversuch, C. J. et al. Reduction in heart rate variability in patients with systemic lupus erythematosus. J. Rheumatol. 24, 1540–1544 (1997).

    CAS  PubMed  Google Scholar 

  78. Lindgren, S., Stewenius, J., Sjolund, K., Lilja, B. & Sundkvist, G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand. J. Gastroenterol. 28, 638–642 (1993).

    Article  CAS  PubMed  Google Scholar 

  79. Uslu, N. et al. Heart rate variability in patients with systemic sarcoidosis. Ann. Noninvasive Electrocardiol. 11, 38–42 (2006).

    Article  PubMed  PubMed Central  Google Scholar 

  80. Biswas, A. K., Scott, W. A., Sommerauer, J. F. & Luckett, P. M. Heart rate variability after acute traumatic brain injury in children. Crit. Care Med. 28, 3907–3912 (2000).

    Article  CAS  PubMed  Google Scholar 

  81. Hanson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nature Rev. Immunol. 6, 508–519 (2006).

    Article  CAS  Google Scholar 

  82. Sloan, R. P. et al. RR interval variability is inversely related to inflammatory markers: the CARDIA study. Mol. Med. 13, 178–184 (2007).

    Article  PubMed  PubMed Central  Google Scholar 

  83. Bhatia, M., Zhi, L., Zhang, H., Ng, S. W. & Moore, P. K. Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice. Am. J. Physiol. Lung Cell Mol. Physiol. 291, L896–L904 (2006).

    Article  CAS  PubMed  Google Scholar 

  84. Spengler, R. N., Chensue, S. W., Giacherio, D. A., Blenk, N. & Kunkel, S. L. Endogenous norepinephrine regulates tumor necrosis factor-alpha production from macrophages in vitro. J. Immunol. 152, 3024–3031 (1994).

    CAS  PubMed  Google Scholar 

  85. Yu, B. et al. Serotonin 5-hydroxytryptamine2A receptor activation suppresses tumor necrosis factor-α-induced inflammation with extraordinary potency. J. Pharmacol. Exp. Ther. 327, 316–323 (2008).

    Article  CAS  PubMed  Google Scholar 

  86. Yoshimura, T. et al. Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Pharmacology 54, 144–152 (1997).

    Article  CAS  PubMed  Google Scholar 

  87. Pavlov, V. A. et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc. Natl Acad. Sci. USA 103, 5219–5223 (2006).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Pavlov, V. A. et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23, 41–45 (2009).

    Article  CAS  PubMed  Google Scholar 

  89. Labiner, D. M. & Ahern, G. L. Vagus nerve stimulation therapy in depression and epilepsy: therapeutic parameter settings. Acta Neurol. Scand. 115, 23–33 (2007).

    Article  PubMed  Google Scholar 

  90. DeGiorgio, C. M. et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 41, 1195–1200 (2000).

    Article  CAS  PubMed  Google Scholar 

  91. Sanders, V. M. & Straub, R. H. Norepinephrine, the β-adrenergic receptor, and immunity. Brain Behav. Immun. 16, 290–332 (2002).

    Article  CAS  PubMed  Google Scholar 

  92. Saravia, F. & Homo-Delarche, F. Is innervation an early target in autoimmune diabetes? Trends Immunol. 24, 574–579 (2003).

    Article  CAS  PubMed  Google Scholar 

  93. Straub, R. H., Rauch, L., Fassold, A., Lowin, T. & Pongratz, G. Neuronally released sympathetic neurotransmitters stimulate splenic interferon-γ secretion from T cells in early type II collagen-induced arthritis. Arthritis Rheum. 58, 3450–3460 (2008).

    Article  CAS  PubMed  Google Scholar 

  94. van Maanen, M. A. et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum. 60, 114–122 (2009).

    Article  CAS  PubMed  Google Scholar 

  95. Zhang, P., Han, D., Tang, T., Zhang, X. & Dai, K. Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm. Res. 57, 322–328 (2008).

    Article  CAS  PubMed  Google Scholar 

  96. Dampney, R. A. et al. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin. Exp. Pharmacol. Physiol. 32, 419–425 (2005).

    Article  CAS  PubMed  Google Scholar 

  97. Huston, J. M. et al. Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit. Care Med. 35, 2762–2768 (2007).

    PubMed  Google Scholar 

  98. Kawada, T. et al. Vagal stimulation suppresses ischemia-induced myocardial interstitial myoglobin release. Life Sci. 83, 490–495 (2008).

    Article  CAS  PubMed  Google Scholar 

  99. Ghia, J. E., Blennerhassett, P., El Sharkawy, R. T. & Collins, S. M. The protective effect of the vagus nerve in a murine model of chronic relapsing colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G711–G718 (2007).

    Article  CAS  PubMed  Google Scholar 

  100. Ghia, J. E., Blennerhassett, P. & Collins, S. M. Vagus nerve integrity and experimental colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G560–G567 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author thanks S. Chavan, M. Rosas-Ballina, V. Pavlov, B. Volpe, P. Huerta, B. Diamond and S. Warren for helpful discussions. Work in the author's laboratory was supported in part by the National Institute of General Medical Sciences, one of the National Institutes of Health.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

K. Tracey is an inventor on patents related to the cholinergic anti-inflammatory pathway and is a consultant on this topic.

Related links

Related links

FURTHER INFORMATION

The Feinstein Institute homepage

Glossary

Sickness syndrome

The physiological and behavioural responses to the molecular products of infection or injury that can be triggered by the accumulation of pro-inflammatory cytokines in the brain. These include (but are not limited to) fever, acute phase responses, anorexia, weight loss, increased sleep, decreased social interaction, exploration, decreased sexual activity and altered hypothalamic, pituitary and autonomic output.

Pyrogen

An agent that is derived from either a pathogen or the host and that can cause fever in vivo. Examples of pyrogens include bacterial endotoxin and cytokines, such as tumour necrosis factor, interleukin-1 (IL-1) and IL-6.

Glomus cell

A type of epithelial cell located in the carotid body or in clusters (termed paraganglia) adjacent to the vagus and other autonomic nerves. A glomus cell can be activated by chemical changes in the cellular milieu to release dopamine or other neurotransmitters close to nerves.

Pathogen-associated molecular pattern

A microbial motif that can stimulate innate immune responses; for example, bacterial endotoxins, peptidoglycan, flagellin, double-stranded RNA and unmethylated CpG-containing DNA.

Toll-like receptor

A membrane receptor that is expressed by innate immune cells and that interacts with molecular products of infection or injury to initiate cytokine release and trigger inflammation.

Damage-associated molecular pattern

A molecule that is produced by the host and that can stimulate innate immune responses; for example, high-mobility group box protein, uric acid, heat shock proteins, heparin sulphate, hyaluronan fragments, ATP and DNA.

Nucleotide-binding oligiomerization domain (NOD)-like receptor

An intracellular pattern recognition receptor belonging to a family comprising 20 members that recognize endogenous or exogenous molecular products of infection or injury, several of which activate caspases that activate cytokine release and nuclear factor-κB signalling.

Sepsis

A systemic inflammatory syndrome that occurs after infection or injury and is characterized by a constellation of symptoms, including, but not limited to, alterations in body temperature, white blood cell count, heart rate, respiratory rate and organ function.

Catecholamines

A family of catechol-containing molecules, including adrenaline, noradrenaline and dopamine, which are produced by chromaffin cells of the adrenal medulla and are released as neurotransmitters from postganglionic fibres in the sympathetic nervous system.

Set point

The magnitude of a function in physiology and metabolism (for example, mean arterial blood pressure or body temperature) targeted as the output of homeostasis, such that deviations away from this target initiate compensatory reflexes to adjust the output back to that target.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tracey, K. Reflex control of immunity. Nat Rev Immunol 9, 418–428 (2009). https://doi.org/10.1038/nri2566

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nri2566

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing